Skip to main content
Premium Trial:

Request an Annual Quote

Forsyth, Kuwaiti Organizations Collaborate on Type 2 Diabetes Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Forsyth Institute today announced a research collaboration with the Dasman Diabetes Institute of Kuwait directed at type 2 diabetes in children.

The five-year agreement will also explore conditions that predispose children to obesity and research will be directed at maintaining metabolic health in children, Forsyth said in a statement. The Kuwait Dental School is also participating in the alliance.

Forsyth added that Kuwaiti scientists will largely manage the clinical research.

Financial terms of the partnership were not disclosed.

Scientists at Forsyth, based in Cambridge, Mass., will focus on discovering biomarkers in saliva that may indicate metabolic disease and the development of diabetes. A spokesperson for Forsyth said that the biomarkers being explored are proteins, metabolites, and oral microbes.

The Forsyth team is being led by J. Max Goodson, who is developing diagnostic tools suitable for the large-scale investigation of disease conditions in children that lead to diabetes.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.